GE HealthCare Technologies Inc. (GEHC)
(Real Time Quote from BATS)
$87.74 USD
+0.95 (1.10%)
Updated Sep 18, 2024 10:26 AM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Income Statements
Fiscal Year end for GE HealthCare Technologies Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 19,552 | 18,341 | 17,585 | 17,164 | 16,633 |
Cost Of Goods | 11,630 | 11,162 | 10,411 | 10,397 | 10,085 |
Gross Profit | 7,922 | 7,179 | 7,174 | 6,767 | 6,548 |
Selling & Adminstrative & Depr. & Amort Expenses | 5,487 | 4,657 | 4,379 | 4,047 | 4,424 |
Income After Depreciation & Amortization | 2,435 | 2,522 | 2,795 | 2,720 | 2,124 |
Non-Operating Income | -74 | -10 | 80 | -10 | -33 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 2,361 | 2,512 | 2,875 | 2,710 | 2,091 |
Income Taxes | 743 | 563 | 600 | 652 | 410 |
Minority Interest | 46 | 51 | 46 | 51 | 29 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 1,618 | 1,949 | 2,275 | 2,058 | 1,681 |
Extras & Discontinued Operations | -4 | 18 | 18 | 11,839 | -128 |
Net Income (GAAP) | 1,568 | 1,916 | 2,247 | 13,846 | 1,524 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 3,045 | 3,155 | 3,420 | 3,350 | 2,783 |
Depreciation & Amortization (Cash Flow) | 610 | 633 | 625 | 630 | 659 |
Income After Depreciation & Amortization | 2,435 | 2,522 | 2,795 | 2,720 | 2,124 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 458.00 | 454.07 | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | 3.93 | 4.63 | NA | NA | NA |
Diluted Net EPS (GAAP) | 3.03 | 4.22 | NA | NA | NA |
Fiscal Year end for GE HealthCare Technologies Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 4,839.00 | 4,650.00 | 5,206.00 | 4,822.00 | 4,817.00 |
Cost Of Goods | 2,837.00 | 2,749.00 | 3,050.00 | 2,887.00 | 2,877.00 |
Gross Profit | 2,002.00 | 1,901.00 | 2,156.00 | 1,935.00 | 1,940.00 |
SG&A, R&D, and Dept/Amort Expenses | 1,394.00 | 1,362.00 | 1,467.00 | 1,318.00 | 1,370.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 608.00 | 539.00 | 689.00 | 617.00 | 570.00 |
Non-Operating Income | -29.00 | -28.00 | -80.00 | 19.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 578.00 | 511.00 | 609.00 | 636.00 | 570.00 |
Income Taxes | 143.00 | 124.00 | 193.00 | 250.00 | 137.00 |
Minority Interest | 7.00 | 14.00 | 13.00 | 7.00 | 15.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 435.00 | 387.00 | 416.00 | 386.00 | 433.00 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | -4.00 | 0.00 |
Net Income (GAAP) | 428.00 | 373.00 | 403.00 | 375.00 | 418.00 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 459.00 | 459.00 | 458.00 | 458.00 | 458.00 |
Diluted EPS Before Non-Recurring Items | 1.00 | 0.90 | 1.18 | 0.99 | 0.92 |
Diluted Net EPS (GAAP) | 0.93 | 0.81 | 0.89 | 0.82 | 0.91 |